We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.51B
AUM Growth
+$157M
(+12%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
8.67%
Top 10 Holdings %
Top 10 Hldgs %
43.35%
Holding
93
New
19
Increased
39
Reduced
13
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CUTR
Cutera, Inc.
CUTR
|
+$36.8M |
| 2 |
Aldeyra Therapeutics
ALDX
|
+$30.2M |
| 3 |
Sutro Biopharma
STRO
|
+$29.2M |
| 4 |
NeoGenomics
NEO
|
+$25.3M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$86.4M |
| 2 |
CareDx
CDNA
|
+$44.6M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$26.6M |
| 4 |
Halozyme
HALO
|
+$25.6M |
| 5 |
Arrowhead Research
ARWR
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.27% |
| 2 | Communication Services | 4.55% |
| 3 | Energy | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNE
1
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $94.4M | 6.26% |
5,426,241
+74,748
| +1% | +$1.34M |
|
|
2
Halozyme
HALO
$9.79B
| $83.9M | 5.56% |
2,011,350
-560,542
| -22% | -$25.6M |
|
|
3
CareDx
CDNA
$2.26B
| $82.6M | 5.47% |
1,212,677
-574,960
| -32% | -$44.6M |
|
4
Prothena Corp
PRTA
$425M
| $73.7M | 4.89% |
2,935,707
+879,254
| +43% | +$16.5M |
|
|
MODN
5
DELISTED
MODEL N, INC.
MODN
| $68.7M | 4.55% |
1,949,762
+639,749
| +49% | +$24.6M |
|
6
AtriCure
ATRC
$1.92B
| $54.3M | 3.6% |
828,002
+18,692
| +2% | +$1.15M |
|
7
Axogen
AXGN
$2.27B
| $51.8M | 3.44% |
2,557,412
+418,278
| +20% | +$8.26M |
|
8
Omnicell
OMCL
$1.61B
| $49.2M | 3.26% |
379,075
-61,171
| -14% | -$7.85M |
|
|
9
NeoGenomics
NEO
$1.96B
| $48.4M | 3.21% |
1,003,216
+486,125
| +94% | +$25.3M |
|
|
10
Sutro Biopharma
STRO
$401M
| $46.9M | 3.11% |
205,845
+123,135
| +149% | +$29.2M |
|
11
Health Catalyst
HCAT
$154M
| $46.6M | 3.09% |
997,201
+25,304
| +3% | +$1.23M |
|
12
Tandem Diabetes Care
TNDM
$1.34B
| $46.3M | 3.07% |
525,129
+257,855
| +96% | +$24M |
|
13
Glaukos
GKOS
$9.83B
| $44.7M | 2.96% |
532,657
-145,650
| -21% | -$12.8M |
|
|
XENT
14
DELISTED
Intersect ENT, Inc
XENT
| $42.5M | 2.82% |
2,036,645
+813,684
| +67% | +$18.8M |
|
15
Teva Pharmaceuticals
TEVA
$40.8B
| $42.4M | 2.81% |
3,674,104
+282,692
| +8% | +$3.24M |
|
16
Krystal Biotech
KRYS
$10.1B
| $37.9M | 2.51% |
491,511
-229
| -0% | -$16.6K |
|
|
CUTR
17
DELISTED
Cutera, Inc.
CUTR
| $37.4M | 2.48% |
+1,244,117
| New | +$36.8M |
|
|
18
Arrowhead Research
ARWR
$11.9B
| $35.6M | 2.36% |
536,836
-167,613
| -24% | -$13M |
|
19
Insmed
INSM
$21.4B
| $32.4M | 2.15% |
950,953
-120,266
| -11% | -$4.6M |
|
|
20
Aldeyra Therapeutics
ALDX
$92.9M
| $31.2M | 2.07% |
+2,624,001
| New | +$30.2M |
|
|
KRTX
21
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $31.1M | 2.06% |
258,500
+121,100
| +88% | +$13.7M |
|
22
OptimizeRx
OPRX
$114M
| $29M | 1.92% |
594,199
-91,501
| -13% | -$4.41M |
|
|
YMAB
23
DELISTED
Y-mAbs Therapeutics
YMAB
| $28.6M | 1.89% |
944,253
+308,601
| +49% | +$12.7M |
|
24
Ultragenyx Pharmaceutical
RARE
$2.45B
| $24.8M | 1.64% |
217,459
+3,572
| +2% | +$486K |
|
25
Genmab
GMAB
$17.7B
| $24.2M | 1.6% |
737,261
+100,177
| +16% | +$3.77M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, First Light Asset Management held 93 positions worth $1.51B, up 12% from $1.35B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Light Asset Management deployed $131M of net new capital in Q1 2021, opening 19 new positions and adding to 39 existing holdings. Its largest new stake was Cutera, Inc.: 1,244,117 shares worth $37.4M.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 86% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was CareDx, an estimated $44.6M trimmed.
- First Light Asset Management's largest Q1 2021 buy was Cutera, Inc.: 1,244,117 shares worth $37.4M.
- First Light Asset Management added most to Sutro Biopharma in Q1 2021, an estimated $29.2M increase.
- First Light Asset Management's biggest Q1 2021 reduction was CareDx, cutting an estimated $44.6M.
- First Light Asset Management fully exited Oxford Immunotec Global PLC Ordinary Shares in Q1 2021, selling an estimated $86.4M.
- First Light Asset Management's ten largest holdings make up 43% of its $1.51B portfolio in Q1 2021.
- First Light Asset Management opened 19 new positions and closed 16 in Q1 2021.
- First Light Asset Management's portfolio value rose 12% quarter-over-quarter to $1.51B.
Based on First Light Asset Management's 13F filing for Q1 2021, filed 17 May 2021.